To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
-
Microtubule-Associated Protein Tau Plasmids
DNA Plasmids encoding various MAPT cDNA inserts
-
LEGEND MAX™ Human Alpha-Synuclein ELISA Kit*
ELISA kit developed in collaboration with Covance for measuring human alpha-synuclein protein in biological samples. The assay has been demonstrated to conform to AAPS performance criteria using CSF as a matrix. Please note, this assay was previously made available as an ECL ELISA but has since switched to Colorimetric.
-
DNAJ26 Plasmids
DNA Plasmids encoding various DNAJ26 cDNA inserts
-
VPS35 D620N Mouse
Mice expressing the D620N mutant form of VPS35. RRID:IMSR_JAX:023409
-
Cell line stably lacking LRRK2 expression (KO) (Type: Raw 264.7 macrophages)
RAW 264.7 macrophage cell line with a knockout of endogenous mouse LRRK2 protein using zinc-finger nuclease (ZFN)-assisted adeno viral vector (AAV) technology to generate a stable cell line.
-
DJ-1 Plasmids
DNA Plasmids encoding various DJ-1 cDNA inserts
-
LRRK2 Plasmids
DNA Plasmids encoding various LRRK2 cDNA inserts
-
GBA D409V Knockin Mouse
Knockin mice expressing the D409V mutant form of GBA on the C57BL/6N mouse background.
Generated as part of the Industry Tools Consortium. RRID:IMSR_JAX:019106
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic